Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations
Cancers | Free Full-Text | Pathology and Classification of SCLC
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR | Oncotarget
Cancers | Free Full-Text | Pathology and Classification of SCLC
Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma | Science Advances
Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer | eLife
Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis
Nneha Sakre PhD - Biosafety Specialist II - Stanford University | LinkedIn
A multiplexed in vivo approach to identify driver genes in small cell lung cancer - ScienceDirect
Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer | Science Advances
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications: Molecular Therapy - Oncolytics
Stable RET expression and signaling in small-cell lung cancer cell... | Download Scientific Diagram
Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer
SCLC YAP1 Subtype: Potential for Personalized Therapy? - Small Cell Lung Cancer: Contemporary Concepts
Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma | Science Advances
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate - ScienceDirect
Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histological transformation | bioRxiv
YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways - Song - 2020 - Cancer Medicine - Wiley Online Library
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization - ScienceDirect
SCLC_CellMiner: Integrated Genomics and Therapeutics Predictors of Small Cell Lung Cancer Cell Lines based on their genomic signatures | bioRxiv
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications - ScienceDirect
Cancers | Free Full-Text | Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer
YAP drives fate conversion and chemoresistance of small cell lung cancer | Science Advances
Chemo-sensitivity of SCLC subgroups. A. Survival analysis based upon... | Download Scientific Diagram
